New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel

3.00 Dollar US$
June 6, 2024 United States, Arizona, Anthem 12

Description

New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panelNew COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panelNew COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panelNew COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panelNew COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel


Share by email Share on Facebook Share on Twitter Share on Google+ Share on LinkedIn Pin on Pinterest